Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 3, 2011, Pages 236-243

  Syed Ahamed Kabeer, Basirudeen ^a   Sikhamani, Rajasekaran ^b   Raja, Alamelu ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b Government Hospital for Thoracic Medicine   (India)

Author keywords

Diagnosis; Human immunodeficiency virus; Interferon gamma inducible protein 10; QuantiFERON TB Gold in tube; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CHEMOKINE CXCL10; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 80053919862     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.07.012     Document Type: Article

References (45)

1. Adetifa I.M., Lugos M.D., Hammond A., Jeffries D., Donkor S., Adegbola R.A., et al. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect. Dis. 2007, 7:122.
2. Andersen A.B., Brennan P. Proteins and antigens of Mycobacterium tuberculosis. Tuberculosis: pathogenesis, protection, and control 1994, 307-332. American Society for Microbiology, Washington DC. B.R. Bloom (Ed.).
3. Azzurri A., Sow O.Y., Amedei A., Bah B., Diallo S., Peri G., et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 2005, 7:1-8.
4. Balcells M.E., Perez C.M., Chanqueo L., Lasso M., Villanueva M., Espinoza M., et al. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int. J. Infect. Dis. 2008, 12:645-652.
5. Brock I., Ruhwald M., Lundgren B., Westh H., Mathiesen L.R., Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir. Res. 2006, 7:56.
6. Converse P.J., Jones S.L., Astemborski J., Vlahov D., Graham N.M. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J. Infect. Dis. 1997, 176:144-150.
7. Dheda K., van Zyl Smit R., Badri M., Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr. Opin. Pulm. Med. 2009, 15:188-200.
8. Dheda K., Van-Zyl Smit R.N., Sechi L.A., Badri M., Meldau R., Symons G., et al. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 2009, 4:e4689.
9. Dhillon N.K., Peng F., Ransohoff R.M., Buch S. PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia. J. Immunol. 2007, 179:2722-2730.
10. Diagnostic Standards and Classification of Tuberculosis in Adults and Children This official statement of the American Thoracic Society (ATS) and the Centers for Disease Control (CDC) and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am. J. Respir. Crit. Care Med. 2000, 161:1376-1395.
11. Farhat M., Greenaway C., Pai M., Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int. J. Tuberc. Lung Dis. 2006, 10:1192-1204.
12. Ferrara G., Losi M., Meacci M., Meccugni B., Piro R., Roversi P., et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 2005, 172:631-635.
13. Goletti D., Raja A., Ahamed Kabeer B.S., Rodrigues C., Sodha A., Butera O., et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J. Infect. 2010, 61:133-143.
14. Goletti D., Raja A., Syed Ahamed Kabeer B., Rodrigues C., Sodha A., Carrara S., et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?. PLoS One 2010, 5:e12577.
15. Grant A.D., Charalambous S., Fielding K.L., Day J.H., Corbett E.L., Chaisson R.E., et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA 2005, 293:2719-2725.
16. Hill P.C., Fox A., Jeffries D.J., Jackson-Sillah D., Lugos M.D., Owiafe P.K., et al. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin. Infect. Dis. 2005, 40:273-278.
17. Hiransuthikul N., Nelson K.E., Hiransuthikul P., Vorayingyong A., Paewplot R. INH preventive therapy among adult HIV-infected patients in Thailand. Int. J. Tuberc. Lung. Dis. 2005, 9:270-275.
18. Huebner R.E., Schein M.F., Bass J.B. The tuberculin skin test. Clin. Infect. Dis. 1993, 17:968-975.
19. Juffermans N.P., Verbon A., van Deventer S.J., van Deutekom H., Belisle J.T., Ellis M.E., et al. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect. Immun. 1999, 67:4295-4297.
20. Kabeer B.S., Sikhamani R., Raja A. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 2010, 24:323-325.
21. Kabeer B.S.A., Perumal V., Paramasivan P., Raja A. Yield of QuantiFERON-TB gold in tube assay and tuberculin skin test in healthy subjects from a tuberculosis endemic population. J. Pediatr. Infect. Dis. 2010, 5:1-5.
22. Karam F., Mbow F., Fletcher H., Senghor C.S., Coulibaly K.D., LeFevre A.M., et al. Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One 2008, 3:e1441.
23. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007, 8:369-377.
24. Lagrange P.H., Herrmann J.L. Diagnosing latent tuberculosis infection in the HIV era. Open Respir. Med. J. 2008, 2:52-59.
25. Lighter J., Rigaud M., Eduardo R., Peng C.H., Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 2009, 123:30-37.
26. Markowitz N., Hansen N.I., Hopewell P.C., Glassroth J., Kvale P.A., Mangura B.T., et al. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann. Intern. Med. 1997, 15:123-132.
27. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2001, 2:123-128.
28. Okamoto M., Kawabe T., Iwasaki Y., Hara T., Hashimoto N., Imaizumi K., et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J. Lab. Clin. Med. 2005, 145:88-93.
29. Pai M., Gokhale K., Joshi R., Dogra S., Kalantri S., Mendiratta D.K., et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005, 293:2746-2755.
30. Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis. Expert Rev. Mol. Diagn. 2006, 6:413-422.
31. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 2008, 149:177-184.
32. Pai M., Joshi R., Dogra S., Zwerling A.A., Gajalakshmi D., Goswami K., et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int. J. Tuberc. Lung Dis. 2009, 13:84-92.
33. Pape J.W., Jean S.S., Ho J.L., Hafner A., Johnson J.B. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993, 342:268-272.
34. Raby E., Moyo M., Devendra A., Banda J., De Haas P., Ayles H., et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008, 3:e2489.
35. Ragno S., Romano M., Howell S., Pappin D.J., Jenner P.J., Colston M.J. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology 2001, 104:99-108.
36. Rangaka M.X., Wilkinson K.A., Seldon R., Van Cutsem G., Meintjes G.A., Morroni C., et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am. J. Respir. Crit. Care Med. 2007, 175:514-520.
37. Ruhwald M., Bodmer T., Maier C., Jepsen M., Haaland M.B., Eugen-Olsen J., et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J 2008, 32:1607-1615.
38. Santin M., Casas S., Saumoy M., Andreu A., Moure R., Alcaide F., Ferrer E., Podzamczer D. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons. Diagn. Microbiol. Infect. Dis. 2011, 69:59-65.
39. Swaminathan S., Subbaraman R., Venkatesan P., Subramanyam S., Kumar S.R., Mayer K.H., et al. Tuberculin skin test results in HIV-infected patients in India: implications for latent tuberculosis treatment. Int. J. Tuberc. Lung Dis. 2008, 12:168-173.
40. Syed Ahamed Kabeer B., Sikhamani R., Swaminathan S., Perumal V., Paramasivam P., Raja A. Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One 2009, 4:e5718.
41. Syed Ahamed Kabeer B., Raman B., Thomas A., Perumal V., Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 2010, 5:e9051.
42. Whalen C.C., Chiunda A., Zalwango S., Nshuti L., Jones-Lopez E., Okwera A., et al. Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda. Am. J. Trop. Med. Hyg. 2006, 75:55-61.
43. Whittaker E., Gordon A., Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?. PLoS One 2008, 3:e3901.
44. WHO WHO Statistical Information System. Available online at. http://www.who.int/whosis/en.
45. WHO Global Tuberculosis Programme, UNAIDS. Policy statement on preventative therapy against tuberculosis in people living with HIV. WHO/TB/98.255 and UNAIDS/98.34 1998, WHO, Geneva, Switzerland.